Hamaguchi and colleagues identified RhoBTB2 in a representational difference analysis screen for novel tumor suppressor genes in breast cancer, and gave it the alternative name DBC2 (deleted in breast cancer 2). This evidence concerns the gene RHOBTB2 and breast cancer.